Theratechnologies Announces FDA Approval of Trogarzo
Theratechnologies Announces FDA Approval of Trogarzo
Mar 06, 2018
Supporting Materials:
Theratechnologies Inc. (Theratechnologies) (TSX:TH) and its partner TaiMed Biologics, Inc. (TaiMed) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Trogarzo™ (ibalizumabuiyk) Injection.